1291764

Lianyungang Kangle Pharmaceutical Co., Ltd. — FEI 3010728729

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 19, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Lianyungang (China)